Sanofi — Director's Dealing 2015

Nov 12, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Voyager Therapeutics, Inc. (VYGR)
CIK: 0001640266
Period of Report: 2015-11-10

Reporting Person: Sanofi (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Shares of Series B convertible preferred stock	$0		Common stock (2352941)		Indirect

Footnotes

F1: Converts into common stock

F2: Conversion upon Initial Public Offering